Results 121 to 130 of about 7,077 (179)

Non-invasive brain stimulation for neuropathic orofacial pain: a mini-review. [PDF]

Front Pain Res (Lausanne)
Lin X, Niu X, Hu T, Zhang J, Diao Y, Li J, Yang Q, Liao C, Xin T, Li S, Fu X, Du K, Cheng J.   +12 more
europepmc   +1 more source

Comparison of efficacy and safety of non-oral therapeutic interventions for zoster-associated pain: a systematic review and network meta-analysis. [PDF]

Front Neurol
Hao Y, Liu X, Ma X, Sun T.
europepmc   +1 more source

Cognitive dysfunction and hippocampal metabolic alterations in patients with postherpetic neuralgia. [PDF]

Front Neurol
Ni X, Yuan Y, Wang J, Liu H, Zhang Y, Yan Y, Han J.   +6 more
europepmc   +1 more source

Epidemiology and risk factors of postherpetic neuralgia worldwide: protocol for a systematic review and meta-analysis. [PDF]

BMJ Open
Liao X, Xu S, Wang Y, Zheng B.
europepmc   +1 more source

Effect of Erector Spinae Plane Block Applied to Painful Herpes Zoster Patients Who Failed to Respond to Pregabalin Treatment on Immunological Marker Levels and Postherpetic Neuralgia Incidence Rate. [PDF]

J Pain Res
Büyükbezirci G, Demiralp N, Keles S, Yılmaz R, Arıcan Ş, Tuncer Uzun S, Reisli R, Reisli İ.   +7 more
europepmc   +1 more source

Zoster Segmental Paralysis: Clinical and Electrodiagnostic Features in a Retrospective Case Series of 17 Patients. [PDF]

Cureus
Shields LB, Iyer VG, Shields CB.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Postherpetic Neuralgia

Journal of Pain & Palliative Care Pharmacotherapy, 2011
Questions from patients about analgesic pharmacotherapy and responses from authors are presented to help educate patients and make them more effective self-advocates. The topic addressed in this issue is postherpetic neuralgia, symptoms, risk factors, and treatment.
Tabitha A. Washington, Khalilah M. Brown, Gilbert J. Fanciullo   +2 more
openaire   +3 more sources

Postherpetic Neuralgia

Archives of Neurology, 1986
Postherpetic pain persisting one month or longer occurs in 9% to 14% of patients with herpes zoster, diminishing with time. The incidence and duration are directly related to age. The pathologic features have been described but the pathogenesis of postherpetic neuralgia is unknown. Treatment remains difficult.
P N, Watson, R J, Evans
  +7 more sources

The prognosis with postherpetic neuralgia

Pain, 1991
One hundred and fifty-six patients with moderate to severe postherpetic neuralgia (PHN) were followed for up to 11 years. Nearly half of all patients were doing well at the final assessment (median 2 years) and more than half of these were on no therapy at this time.
Peter N C, Watson, Verna R, Watt, Mary, Chipman, Nicholas, Birkett, Ramon J, Evans   +4 more
openaire   +2 more sources